Ketamine Beating Psilocybin in Race for Patients

With the state of Oregon's move to decriminalize drugs, the stigma around compounds like ketamine is lessening.

Zebra Technologies Could Correct in the Weeks Ahead

The shares have more than doubled from their March nadir.

Trupanion Could Be the Cat's Meow for Investors

Here's what might happen next for shares of the pet insurance company.

Jim Cramer: Celebrating a Vaccine!

It's so huge. Hard to grasp. It's incredible.

CVS Is Aggressive and Optimistic, and I'm Long the Shares

The firm's Q3 earnings easily beat Wall Street's expectations.

Can UnitedHealth Group and Cigna Stay Healthy?

Let's see if UNH and CI are what the doctor ordered.

Teladoc Could Rally From Here

Is Teladoc's merger with Livongo Health a 'game changer' for the stock?

Humana's Charts Are Not as Healthy as We Would Like

The company is set to report earnings Tuesday.

Here's a Dividend Aristocrat Trading at a Discount

With 33 years of consecutive dividend increases, this health care name is a member of the Dividend Aristocrats Index.